Literature DB >> 26309654

Cuffed-tunneled hemodialysis catheter survival and complications in pediatric patients: a single-center data analysis in China.

Kai Wang1, Pei Wang1, Xian-Hui Liang1, Fang-Fang Yuan1, Zhang-Suo Liu1.   

Abstract

This study aims to evaluate the outcome and complications of cuffed-tunneled catheters in pediatric patients. Between January 2010 and December 2013, 16 pediatric patients with end-stage renal disease (ESRD) were included. 21 cuffed-tunneled hemodialysis catheters were inserted in patients for long-term hemodialysis access. No serious complications were observed in all patients receiving catheter insertion operation, except one with hemopneumothorax. Median survival time was 413.5 days, with rate being 67.5% in the first year, 51.5% in the second year and 43.6% in the third year. Among attempted catheter insertions, 21 (100%) achieved successful vascular access with 13 (61.9%) being remained for the required period and 8 (38.1%) being removed due to death, intractable blood or tunnel infections, catheter thrombosis or malposition. The overall rate of catheter-related infections, thrombosis and malposition was 7.3, 23.4 and 3.4 episodes/1000 catheter days, respectively. Cuffed-tunneled hemodialysis catheters could be effectively used for maintenance of hemodialysis vascular access for pediatric patients with ESRD. Various surveillance measures should be taken to ensure cuffed-tunneled catheters' long-term patency.

Entities:  

Keywords:  Complications; cuffed-tunneled hemodialysis catheter; hemodialysis; survival

Year:  2015        PMID: 26309654      PMCID: PMC4538004     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  Outcome of tunneled hemodialysis catheters placed by radiologists.

Authors:  G B Lund; S O Trerotola; P F Scheel; S J Savader; S E Mitchell; A C Venbrux; F A Osterman
Journal:  Radiology       Date:  1996-02       Impact factor: 11.105

2.  Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing.

Authors:  J M Cecka; D W Gjertson; P I Terasaki
Journal:  Pediatr Transplant       Date:  1997-08

3.  Vascular access use in Europe and the United States: results from the DOPPS.

Authors:  Ronald L Pisoni; Eric W Young; Dawn M Dykstra; Roger N Greenwood; Erwin Hecking; Brenda Gillespie; Robert A Wolfe; David A Goodkin; Philip J Held
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

4.  The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998.

Authors:  M Seikaly; P L Ho; L Emmett; A Tejani
Journal:  Pediatr Transplant       Date:  2001-06

5.  Management of hemodialysis catheter-related bacteremia--a 10-year experience.

Authors:  P G Chawla; T E Nevins
Journal:  Pediatr Nephrol       Date:  2000-03       Impact factor: 3.714

Review 6.  Vascular access for hemodialysis: 2004 and beyond.

Authors:  Prakas T D'Cunha; Anatole Besarab
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-11       Impact factor: 2.894

Review 7.  Catheter-related infections in children treated with hemodialysis.

Authors:  Fabio Paglialonga; Susanna Esposito; Alberto Edefonti; Nicola Principi
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

8.  Central venous catheters as a vascular access modality for pediatric hemodialysis.

Authors:  Fatina Ibrahim Fadel; Hesham Nabil Abdel Mooty; Hafez Mahmoud Bazaraa; Samar Mohamed Sabry
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

9.  A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters.

Authors:  David Wayne Johnson; Robert MacGinley; Troy David Kay; Carmel Mary Hawley; Scott Bryan Campbell; Nicole Maree Isbel; Peter Hollett
Journal:  Nephrol Dial Transplant       Date:  2002-10       Impact factor: 5.992

10.  Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study.

Authors:  E G Lowrie; N M Laird; T F Parker; J A Sargent
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

View more
  5 in total

1.  Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.

Authors:  Ali Mirza Onder; Joseph T Flynn; Anthony A Billings; Fang Deng; Marissa DeFreitas; Chryso Katsoufis; Matthew M Grinsell; Larry T Patterson; Jennifer Jetton; Sahar Fathallah-Shaykh; Daniel Ranch; Diego Aviles; Lawrence Copelovitch; Eileen Ellis; Vimal Chanda; Ayah Elmaghrabi; Jen-Jar Lin; Lavjay Butani; Maha Haddad; Olivera Marsenic Couloures; Paul Brakeman; Raymond Quigley; H Stella Shin; Rouba Garro; Hui Liu; Javad Rahimikollu; Rupesh Raina; Craig B Langman; Ellen G Wood
Journal:  Pediatr Nephrol       Date:  2018-09-27       Impact factor: 3.714

2.  Comparison of high-flux hemodialysis with hemodialysis filtration in treatment of uraemic pruritus: a randomized controlled trial.

Authors:  Xia Jiang; Fen Ji; Zhi-Wei Chen; Qiao-Lin Huang
Journal:  Int Urol Nephrol       Date:  2016-07-05       Impact factor: 2.370

3.  Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative.

Authors:  Olivera Marsenic; Jonathan Rodean; Troy Richardson; Sarah Swartz; Donna Claes; J Christopher Day; Bradley Warady; Alicia Neu
Journal:  Pediatr Nephrol       Date:  2019-10-25       Impact factor: 3.714

4.  Outcome of Cuffed Tunneled Dialysis Catheters for Hemodialysis Patients at a Tertiary Care Hospital: A Descriptive Cross-sectional Study.

Authors:  Kajan Raj Shrestha; Dinesh Gurung; Uttam Krishna Shrestha
Journal:  JNMA J Nepal Med Assoc       Date:  2020-06-30       Impact factor: 0.406

5.  Difficulties with tunneling of the cuffed catheter: a single-centre experience.

Authors:  Tomasz Gołębiowski; Mariusz Kusztal; Krzysztof Letachowicz; Jerzy Garcarek; Tomasz Porażko; Jan Penar; Magdalena Krajewska; Wacław Weyde; Marian Klinger
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.